Acorda Therapeutics, Inc. Operating Expenses
Acorda Therapeutics, Inc. reported Operating Expenses of $141.09 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-11-07
- Acorda Therapeutics, Inc. operating expenses for the quarter ending 2016-09-30 was $141.09M, a 15.16% increase year-over-year.
- Acorda Therapeutics, Inc. operating expenses for the quarter ending 2016-06-30 was $141.49M, a 30.99% increase year-over-year.
- Acorda Therapeutics, Inc. operating expenses for the quarter ending 2016-03-31 was $133.09M, a 31.63% increase year-over-year.
- Acorda Therapeutics, Inc. operating expenses for the quarter ending 2015-12-31 was $127.03M, a 8.85% increase year-over-year.
- Acorda Therapeutics, Inc. operating expenses for fiscal 2015 was $458.67M, a 25.63% increase from fiscal 2014.
- Acorda Therapeutics, Inc. operating expenses for fiscal 2014 was $365.09M, a 19.28% increase from fiscal 2013.
- Acorda Therapeutics, Inc. operating expenses for fiscal 2013 was $306.06M, a 9.23% increase from fiscal 2012.
- Acorda Therapeutics, Inc. operating expenses for fiscal 2012 was $280.21M, a 8.95% increase from fiscal 2011.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $141.09M 10-Q · filed 2016-11-07 | $282.58M derived: sum of 2 quarters · filed 2016-11-07 | $415.67M 10-Q · filed 2016-11-07 | $542.70M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2016-06-30 | $141.49M 10-Q · filed 2016-08-04 | $274.58M 10-Q · filed 2016-08-04 | $401.62M derived: sum of 3 quarters · filed 2016-08-04 | $524.13M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2016-03-31 | $133.09M 10-Q · filed 2016-05-06 | $260.13M derived: sum of 2 quarters · filed 2016-05-06 | $382.64M derived: sum of 3 quarters · filed 2016-11-07 | $490.65M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-12-31 | $127.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $249.54M derived: sum of 2 quarters · filed 2016-11-07 | $357.56M derived: sum of 3 quarters · filed 2016-11-07 | $458.67M 10-K · filed 2016-02-29 | ||||
| 2015-09-30 | $122.51M 10-Q · filed 2016-11-07 | $230.53M derived: sum of 2 quarters · filed 2016-11-07 | $331.64M 10-Q · filed 2016-11-07 | $448.34M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | $108.02M 10-Q · filed 2016-08-04 | $209.13M 10-Q · filed 2016-08-04 | $325.83M derived: sum of 3 quarters · filed 2016-08-04 | $410.96M derived: sum of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | $101.11M 10-Q · filed 2016-05-06 | $217.81M derived: sum of 2 quarters · filed 2016-05-06 | $302.95M derived: sum of 3 quarters · filed 2016-05-06 | $389.10M derived: sum of 4 quarters · filed 2016-05-06 | ||||
| 2014-12-31 | $116.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $201.84M derived: sum of 2 quarters · filed 2016-02-29 | $287.99M derived: sum of 3 quarters · filed 2016-02-29 | $365.09M 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | $85.13M 10-Q · filed 2015-11-09 | $171.28M derived: sum of 2 quarters · filed 2015-11-09 | $248.38M 10-Q · filed 2015-11-09 | $328.23M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $86.15M 10-Q · filed 2015-08-07 | $163.25M 10-Q · filed 2015-08-07 | $243.10M derived: sum of 3 quarters · filed 2016-02-29 | $316.64M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $77.10M 10-Q · filed 2015-05-08 | $156.95M derived: sum of 2 quarters · filed 2016-02-29 | $230.49M derived: sum of 3 quarters · filed 2016-02-29 | $308.81M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $79.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $153.39M derived: sum of 2 quarters · filed 2016-02-29 | $231.71M derived: sum of 3 quarters · filed 2016-02-29 | $306.06M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $73.55M 10-Q · filed 2014-11-07 | $151.86M derived: sum of 2 quarters · filed 2014-11-07 | $226.22M 10-Q · filed 2014-11-07 | $306.37M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $78.31M 10-Q · filed 2014-08-07 | $152.67M 10-Q · filed 2014-08-07 | $232.82M derived: sum of 3 quarters · filed 2015-02-27 | $299.89M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $74.36M 10-Q · filed 2014-05-09 | $154.51M derived: sum of 2 quarters · filed 2015-02-27 | $221.58M derived: sum of 3 quarters · filed 2015-02-27 | $292.18M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $80.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $147.22M derived: sum of 2 quarters · filed 2015-02-27 | $217.82M derived: sum of 3 quarters · filed 2015-02-27 | $280.21M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $67.07M 10-Q · filed 2013-11-07 | $137.67M derived: sum of 2 quarters · filed 2013-11-07 | $200.06M 10-Q · filed 2013-11-07 | $259.68M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-06-30 | $70.60M 10-Q · filed 2013-08-08 | $132.99M 10-Q · filed 2013-08-08 | $192.61M derived: sum of 3 quarters · filed 2014-03-03 | $264.97M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-03-31 | $62.39M 10-Q · filed 2013-05-10 | $122.01M derived: sum of 2 quarters · filed 2014-03-03 | $194.38M derived: sum of 3 quarters · filed 2014-03-03 | $258.73M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2011-12-31 | $59.62M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $131.98M derived: sum of 2 quarters · filed 2014-03-03 | $196.34M derived: sum of 3 quarters · filed 2014-03-03 | $257.18M 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | $72.36M 10-Q · filed 2012-11-08 | $136.72M derived: sum of 2 quarters · filed 2012-11-08 | $197.57M 10-Q · filed 2012-11-08 | $260.25M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $64.36M 10-Q · filed 2012-08-08 | $125.20M 10-Q · filed 2012-08-08 | $187.88M derived: sum of 3 quarters · filed 2013-02-28 | $238.24M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $60.84M 10-Q · filed 2012-05-09 | $123.53M derived: sum of 2 quarters · filed 2013-02-28 | $173.89M derived: sum of 3 quarters · filed 2013-02-28 | $222.43M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $62.68M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $113.04M derived: sum of 2 quarters · filed 2013-02-28 | $161.58M derived: sum of 3 quarters · filed 2013-02-28 | $199.44M 10-K · filed 2013-02-28 | $199.44M 10-K · filed 2011-03-01 | |||
| 2010-09-30 | $50.36M 10-Q · filed 2011-11-07 | $50.36M 10-Q · filed 2010-11-09 | $98.90M derived: sum of 2 quarters · filed 2011-11-07 | $136.75M 10-Q · filed 2011-11-07 | $136.75M 10-Q · filed 2010-11-09 | $173.22M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $48.54M 10-Q · filed 2011-08-08 | $48.54M 10-Q · filed 2010-08-09 | $86.39M 10-Q · filed 2011-08-08 | $86.39M 10-Q · filed 2010-08-09 | $122.86M derived: sum of 3 quarters · filed 2012-02-28 | $157.08M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $37.85M 10-Q · filed 2011-05-09 | $74.32M derived: sum of 2 quarters · filed 2012-02-28 | $108.54M derived: sum of 3 quarters · filed 2012-02-28 | $143.28M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $36.47M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $70.69M derived: sum of 2 quarters · filed 2012-02-28 | $105.43M derived: sum of 3 quarters · filed 2012-02-28 | $135.93M 10-K · filed 2012-02-28 | $135.93M 10-K · filed 2011-03-01 | |||
| 2009-09-30 | $34.21M 10-Q · filed 2010-11-09 | $68.96M derived: sum of 2 quarters · filed 2010-11-09 | $99.46M 10-Q · filed 2010-11-09 | |||||
| 2009-06-30 | $34.74M 10-Q · filed 2010-08-09 | $65.24M 10-Q · filed 2010-08-09 | ||||||
| 2008-12-31 | $121.27M 10-K · filed 2011-03-01 |